Francesca Giunchi

2.6k total citations
105 papers, 1.5k citations indexed

About

Francesca Giunchi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Francesca Giunchi has authored 105 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 40 papers in Surgery and 30 papers in Oncology. Recurrent topics in Francesca Giunchi's work include Prostate Cancer Treatment and Research (34 papers), Prostate Cancer Diagnosis and Treatment (28 papers) and Urologic and reproductive health conditions (20 papers). Francesca Giunchi is often cited by papers focused on Prostate Cancer Treatment and Research (34 papers), Prostate Cancer Diagnosis and Treatment (28 papers) and Urologic and reproductive health conditions (20 papers). Francesca Giunchi collaborates with scholars based in Italy, United States and Sweden. Francesca Giunchi's co-authors include Michelangelo Fiorentino, Francesco Massari, Eugenio Brunocilla, Riccardo Schiavina, Rodolfo Montironi, Massimo Loda, Jessica Carlsson, Sabina Davidsson, Andrea Ardizzoni and Veronica Mollica and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and American Journal of Epidemiology.

In The Last Decade

Francesca Giunchi

100 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Giunchi Italy 23 809 469 451 357 274 105 1.5k
Yoshio Ohno Japan 20 635 0.8× 736 1.6× 526 1.2× 273 0.8× 294 1.1× 107 1.6k
Kutsal Yörükoğlu Türkiye 22 596 0.7× 269 0.6× 511 1.1× 459 1.3× 195 0.7× 144 1.6k
Darrel Drachenberg Canada 19 773 1.0× 378 0.8× 677 1.5× 438 1.2× 213 0.8× 99 1.5k
Cédric Poyet Switzerland 20 751 0.9× 311 0.7× 325 0.7× 394 1.1× 221 0.8× 121 1.5k
Masayuki Mano Japan 23 863 1.1× 372 0.8× 536 1.2× 222 0.6× 161 0.6× 115 1.6k
Michelle R. Downes Canada 21 666 0.8× 391 0.8× 398 0.9× 397 1.1× 286 1.0× 77 1.3k
Philipp Nuhn Germany 21 978 1.2× 433 0.9× 367 0.8× 656 1.8× 427 1.6× 104 1.8k
Yong Mee Cho South Korea 22 807 1.0× 449 1.0× 491 1.1× 687 1.9× 288 1.1× 100 1.8k
Ángel Panizo Spain 19 589 0.7× 300 0.6× 232 0.5× 383 1.1× 209 0.8× 54 1.6k
Steffen Rausch Germany 21 564 0.7× 292 0.6× 476 1.1× 497 1.4× 257 0.9× 122 1.4k

Countries citing papers authored by Francesca Giunchi

Since Specialization
Citations

This map shows the geographic impact of Francesca Giunchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Giunchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Giunchi more than expected).

Fields of papers citing papers by Francesca Giunchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Giunchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Giunchi. The network helps show where Francesca Giunchi may publish in the future.

Co-authorship network of co-authors of Francesca Giunchi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Giunchi. A scholar is included among the top collaborators of Francesca Giunchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Giunchi. Francesca Giunchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rosellini, Matteo, Veronica Mollica, Andrea Marchetti, et al.. (2025). Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience. Pathology - Research and Practice. 270. 155964–155964.
3.
Federico, Alessandro Di, Hugo de Jonge, Andrea De Giglio, et al.. (2024). Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations. JCO Precision Oncology. 8(8). e2400240–e2400240. 2 indexed citations
4.
Ricci, Costantino, Francesca Ambrosi, Francesca Giunchi, et al.. (2023). FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal‐type. Histopathology. 83(3). 465–476. 10 indexed citations
5.
Maloberti, Thais, Antonio De Leo, Elisa Gruppioni, et al.. (2023). Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 24(10). 8940–8940. 3 indexed citations
7.
Federico, Alessandro Di, Andrea De Giglio, Francesco Gelsomino, et al.. (2022). Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes. Cancers. 14(14). 3472–3472. 10 indexed citations
8.
Zelić, Renata, Francesca Giunchi, Jessica Carlsson, et al.. (2022). Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade. SHILAP Revista de lepidopterología. 4 indexed citations
9.
Gaudiano, Caterina, Lorenzo Bianchi, Beniamino Corcioni, et al.. (2022). Beyond Multiparametric MRI and towards Radiomics to Detect Prostate Cancer: A Machine Learning Model to Predict Clinically Significant Lesions. Cancers. 14(24). 6156–6156. 8 indexed citations
10.
Zanoni, Lucia, Riccardo Mei, Lorenzo Bianchi, et al.. (2021). The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis. Cancers. 13(7). 1575–1575. 7 indexed citations
11.
Fiorentino, Michelangelo, Francesca Giunchi, Costantino Ricci, et al.. (2021). Low level of interobserver concordance in assessing histological subtype and tumor grade in patients with penile cancer may impair patient care. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(4). 879–886. 7 indexed citations
12.
Penney, Kathryn L., Svitlana Tyekucheva, Jacob Rosenthal, et al.. (2020). Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum. Molecular Cancer Research. 19(3). 475–484. 28 indexed citations
13.
Giunchi, Francesca, Francesco Massari, Annalisa Altimari, et al.. (2020). Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers. Diagnostics. 10(12). 1109–1109. 5 indexed citations
14.
Ricci, Costantino, Elisa Capizzi, Francesca Giunchi, et al.. (2020). Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study. Therapeutic Advances in Medical Oncology. 12. 3863569842–3863569842. 11 indexed citations
15.
Giunchi, Francesca, Elisa Gruppioni, Annalisa Altimari, et al.. (2020). Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis. Diagnostics. 10(2). 123–123. 3 indexed citations
16.
Giunchi, Francesca, Thomas Gevaert, Marina Scarpelli, & Michelangelo Fiorentino. (2020). Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms. Current Drug Targets. 21(13). 1286–1292. 9 indexed citations
17.
Rizzo, Alessandro, Veronica Mollica, Alessia Cimadamore, et al.. (2020). Is There a Role for Immunotherapy in Prostate Cancer?. Cells. 9(9). 2051–2051. 68 indexed citations
18.
Mollica, Veronica, Alessandro Rizzo, Rodolfo Montironi, et al.. (2020). Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma. Cancers. 12(6). 1449–1449. 71 indexed citations
19.
Capizzi, Elisa, Filippo Gustavo Dall’Olio, Elisa Gruppioni, et al.. (2019). Clinical significance of ROS1 5’ deletions in non-small cell lung cancer. Lung Cancer. 135. 88–91. 11 indexed citations
20.
Capizzi, Elisa, Costantino Ricci, Francesca Giunchi, et al.. (2018). Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer. Lung Cancer. 126. 9–14. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026